ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ADMA is currently covered by 4 analysts with an average price target of $17.25. This is a potential upside of $4.08 (30.98%) from yesterday's end of day stock price of $13.17.

ADMA Biologics's activity chart (see below) currently has 85 price targets and 73 ratings on display. The stock rating distribution of ADMA is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 82.05% of the time, taking 988.82 days on average.

Highest price target for ADMA is $21, Lowest price target is $13, average price target is $17.25.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 05-Nov-2026. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 05-Nov-2026

$13

$-0.17 (-1.29%)

17 days ago
(05-Nov-2026)

10/11 (90.91%)

$-0.21 (-1.59%)

114

Buy Since 04-Jun-2019

$17

$3.83 (29.08%)

$20

4 months 7 days ago
(15-Jul-2026)

10/15 (66.67%)

$8.32 (95.85%)

582

Buy Since 10-May-2024

$21

$7.83 (59.45%)

$10

5 months 4 days ago
(18-Jun-2026)

1/2 (50%)

$12.69 (152.71%)

25

Buy Since 21-Apr-2026

$18

$4.83 (36.67%)

$21

6 months 15 days ago
(07-May-2026)

0/2 (0%)

$9.53 (112.51%)

Buy Since 07-Feb-2019

$26

$18

2 years 14 days ago
(08-Nov-2024)

19/20 (95%)

$3.38 (14.94%)

602

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 989 days for the stock forecasts to be reached, with an average price target met ratio of 82.05%.

Which analyst most recently updated their price target on ADMA (ADMA Biologics)?

Kristen Kluska

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Kristen Kluska works at CANTOR FITZGERALD and has 11 price targets and 7 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Raghuram Selvaraju with the highest potential upside of $12.83

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with the lowest potential downside of -$9.17
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?